Baxter International (BAX) : During the past 4 weeks, traders have been relatively bearish on Baxter International (BAX), hence the stock is down -1.54% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -0.96% relative to the S&P 500. The 4-week change in the price of the stock is -1.75% and the stock has fallen -1.61% in the past 1 week.
Company shares have received an average consensus rating of Hold for the current week The stock has recorded a twenty day Moving Average of 1.95% and the fifty day Moving Average is 0.91%. Baxter International Inc. is up 9.26% in the last three month period. Year-to-Date the stock performance stands at 24.4%.
Baxter International (BAX) : The most positive equity analysts on Baxter International (BAX) expects the shares to touch $60, whereas, the least positive believes that the stock will trade at $47 in the short term. The company is covered by 7 Wall Street Brokerage Firms. The average price target for shares are $50.57 with an expected fluctuation of $4.54 from the mean.
Baxter International (NYSE:BAX): stock turned positive on Friday. Though the stock opened at $47.24, the bulls momentum made the stock top out at $47.54 level for the day. The stock recorded a low of $46.92 and closed the trading day at $47.18, in the green by 0.17%. The total traded volume for the day was 3,197,948. The stock had closed at $47.1 in the previous days trading.
Baxter International Inc. (Baxter) is a diversified healthcare company. The Company operates in two segments: BioScience segment, which include three commercial franchises: Hemophilia, BioTherapeutics and BioSurgery, and Medical Products segment, which include four commercial franchises: Fluid Systems, Renal, Specialty Pharmaceuticals and BioPharma Solutions. Its BioScience processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions, and biosurgery products. Its Medical Products manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps and inhalation anesthetics. Its products are used in hospitals, kidney dialysis centers and nursing homes, among others.